Hims & Hers Health, Inc. (HIMS)
NYSE: HIMS · Real-Time Price · USD
33.68
-3.49 (-9.39%)
At close: Jul 16, 2026, 4:00 PM EDT
32.40
-1.28 (-3.80%)
Pre-market: Jul 17, 2026, 9:17 AM EDT
Hims & Hers Health Employees
Hims & Hers Health had 2,442 employees as of December 31, 2025. The number of employees increased by 805 or 49.18% compared to the previous year.
Employees
2,442
Change (1Y)
805
Growth (1Y)
49.18%
Revenue / Employee
$970,406
Profits / Employee
-$5,420
Market Cap
7.80B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 2,442 | 805 | 49.18% |
| Dec 31, 2024 | 1,637 | 591 | 56.50% |
| Dec 31, 2023 | 1,046 | 395 | 60.68% |
| Dec 31, 2022 | 651 | 253 | 63.57% |
| Dec 31, 2021 | 398 | 217 | 119.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Viatris | 30,000 |
| Dr. Reddy's Laboratories | 27,527 |
| Elanco Animal Health | 9,900 |
| Amneal Pharmaceuticals | 8,700 |
| Alkermes | 2,050 |
| Neurocrine Biosciences | 2,000 |
| Lantheus Holdings | 1,193 |
| Indivior Pharmaceuticals | 838 |
HIMS News
- 3 days ago - Hims & Hers to Announce Second Quarter 2026 Financial Results on August 10, 2026 - Business Wire
- 8 days ago - Hims & Hers (HIMS) Stock Still Has Upside, but Risks Persist - TipRanks
- 14 days ago - Amplify Online Retail ETF Rides a Summer Surge in Performance - ETF Trends
- 15 days ago - Hims & Hers stock jumps as Canaccord lifts target price ahead of FDA review - Invezz
- 16 days ago - HIMS Stock Rallies after Canaccord Raises Price Target to Street-High of $40 - TipRanks
- 22 days ago - Hims' obesity drug business may get boost as employers drop coverage - Reuters
- 4 weeks ago - Living Longer Is Big Business. These Stocks Will Benefit. - Barrons
- 4 weeks ago - Barclays Raises HIMS Stock Price Target on Strong GLP-1 Growth - TipRanks